文献速递甲状腺疾病

儿童甲状腺癌中甲状腺球蛋白抗体的患病率与意义

Prevalence and Significance of Thyroglobulin Antibodies in Pediatric Thyroid Cancer.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

该回顾性队列研究纳入73例≤18岁非髓样甲状腺癌患儿,41%在诊断后6个月内检出甲状腺球蛋白抗体(TgAb),TgAb与淋巴结转移相关(83% vs 53%,P=0.01),中位随访3.8年中44%患儿TgAb转阴,中位转阴时间10.7个月,TgAb阳性与持续或复发疾病无独立关联(OR 3.20,95%CI 0.95-10.80,P=0.06),长期预后意义待确定。

要点

  • 儿童甲状腺癌诊断时TgAb患病率为41%(30/73)。
  • TgAb与淋巴结转移相关(83% vs 53%,P=0.01),与远处转移无关。
  • TgAb转阴者初始TgAb水平较低(中位4.5 vs 76标准化单位,P=0.003)。

核心结论

  • 儿童甲状腺癌诊断时TgAb常见,但近半数患者在1至2年内转阴;TgAb与诊断时淋巴结转移相关,但长期预后意义尚待确定。

研究设计与样本

  • 回顾性队列研究,单中心学术儿科中心,纳入73例连续≤18岁非髓样甲状腺癌患儿,均在诊断后6个月内测量血清TgAb。

主要发现

  • TgAb检出率为41%(30/73),与淋巴结转移相关(83% vs 53%,P=0.01),与远处转移无关。
  • TgAb阳性患者中,中位随访3.8年内44%(11/25)转阴,中位转阴时间10.7个月,11例转阴者中10例(91%)在2年内转阴。
  • TgAb转阴与较低初始TgAb水平相关(中位4.5 vs 76标准化单位,P=0.003)。
  • 诊断时TgAb阳性与持续或复发疾病无独立关联(OR 3.20,95%CI 0.95-10.80,P=0.06)。

关键数值与推荐

  • TgAb与淋巴结转移相关:TgAb阳性组83% vs TgAb阴性组53%(P=0.01)。
  • TgAb转阴者初始TgAb中位4.5标准化单位 vs 未转阴者76标准化单位(P=0.003)。
  • 诊断时TgAb阳性与持续或复发疾病的OR为3.20(95%CI 0.95-10.80,P=0.06)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Circulating thyroglobulin antibodies (TgAb) can confound measurement of serum thyroglobulin and impair thyroid cancer surveillance. Few data exist on the significance of TgAb in pediatric thyroid cancer. OBJECTIVE: To describe the prevalence, natural history, and clinical significance of TgAb in children with thyroid cancer. DESIGN: Retrospective cohort study. SETTING: Single academic pediatric center. PATIENTS: Seventy-three consecutive children (≤18 years) with nonmedullary thyroid cancer who had serum TgAb measured within 6 months after diagnosis. MAIN OUTCOME MEASURES: Prevalence and natural history of TgAb; association of TgAb status and resolution with patient and disease characteristics. RESULTS: TgAb were detected in 41% of subjects (30 of 73) and were associated with lymph node metastasis (83% vs 53%, P = 0.01) but not distant metastasis. In patients with TgAb, resolution occurred in 44% (11 of 25) over a median follow-up of 3.8 years. Median time to clear TgAb was 10.7 months, and 10 of 11 patients who cleared (91%) did so within 2 years. Resolution of TgAb was associated with lower initial TgAb level (median 4.5 vs 76 normalized units, P = 0.003). TgAb positivity at diagnosis was not independently associated with persistent or recurrent disease (odds ratio 3.20, 95% confidence interval 0.95 to 10.80, P = 0.06). CONCLUSIONS: TgAb are common at diagnosis in children with thyroid cancer but resolve in nearly half of patients within 1 to 2 years. TgAb are associated with the presence of lymph node metastasis at diagnosis, but the long-term prognostic significance remains to be determined.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wassner AJ, Della Vecchia M, Jarolim P, et al. Prevalence and Significance of Thyroglobulin Antibodies in Pediatric Thyroid Cancer. J Clin Endocrinol Metab. 2017. PMID: 28398507. doi:10.1210/jc.2017-00286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。